Breast Cancer

Right Breast Carcinoma

Female, 61 years

Patient Internal ID: 9587274

ICD-10 code

C50.2 Malignant Neoplasm of Upper-inner Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

August 2015
Upper-inner Quadrant of Right Breast Carcinoma pT2N0M0 G2 ER+ PR+ HER2 (1+) Stage I. Disease progression in January 2019 with Metastasis in the Liver. On September 2020 Metastasis in the Bones.

Previous Treatment

Surgery, Chemotherapy (Doxorubicin), Chemotherapy (Docetaxel/ Cyclophosphamide), Radiation Therapy, Hormone Therapy (Tamoxifen), Chemotherapy (Paclitaxel/ Gemcitabine), Hormone Therapy (Fulvestrant), Hormone Therapy (Letrozole) and Target Therapy (Palbociclib), Hormone Therapy (Letrozole) and Chemotherapy (Capecitabine).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of around 32 months from diagnosis.

Treatment Provided

Autologous DCV (7 doses) and CIK (4 doses) over a period of 5 months.

Patient Survival/Condition and Year
Date of Review: 18/11/2023

The patient has survived for 34 months since the disease progression. It can be concluded that the addition of Immunotherapy, alongside Hormone Therapy and Chemotherapy, has benefited the patient to exceed median survival by 2 months.